Calcium Channels as Therapeutic Targets

A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Pharmacology".

Deadline for manuscript submissions: 15 August 2024 | Viewed by 218

Special Issue Editors

E-Mail Website
Guest Editor
School of Pharmacy, University of Reading, Whiteknights, PO Box 228, Reading RG6 6AJ, UK
Interests: electrophysiology; voltage-gated calcium channels; cannabinoids; ion channels; GPCRs; pain; ataxia
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Illawarra Health and Medical Research Institute (IHMRI), University of Wollongong, Wollongong, NSW 2522, Australia
Interests: acetylcholine nicotinic receptors; voltage-gated ion channels; venom peptides; conotoxins; structure-function relationship; electrophysiology; nociception
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska Institute & Karolinska University Hospital, C1:68, 141 86 Stockholm, Sweden
Interests: calcium channels; TRPC channels; ion channels
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Ion channels are key modulators of intracellular levels of Ca2+, which, in turn, is a vital physiological ‘second messenger’. Whether modulated through voltage changes, endogenous ligands/protein partners, and/or changes to Ca2+ levels, different Ca2+ channel families represent key molecular targets in a range of pathophysiologies that carry a heavy health, well-being, and economic burden. Thus, Ca2+ channels are major targets in diseases, including pain, epilepsy, neurodegenerative disorders, and neuropsychiatric disorders. Understanding and treating these diseases is increasingly relevant in today’s aging society.

This Special Issue will shed light on new pharmacological agents that modulate different classes of Ca2+ channels, including voltage-gated and transient receptor potential channels and/or the auxiliary subunits that make up the protein complex. We welcome submissions from diverse fields of studies, including, but not limited to, the development of small molecular entities and biological drugs, the development of toxins from the plant and animal kingdoms, the exploitation of knowledge of Ca2+ channel structure and function, and genetic studies of channelopathies and disease association.

Prof. Dr. Gary J. Stephens
Prof. Dr. David Adams
Dr. Hussein N. Rubaiy
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • voltage-gated Ca2+ channels
  • TRP channels
  • Ca2+-permeable TRP and ASIC channels
  • STIM/orai channels
  • Ca2+ channel structure and function
  • Ca2+ channel toxins
  • Ca2+ channelopathies
  • neuropharmacology
  • pain
  • epilepsy
  • neurodegenerative and neuropsychiatric disorders

Published Papers

This special issue is now open for submission.
Back to TopTop